Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)
Jianjun Gao, Shasha Hu
Abstract
Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19. More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19.
Topics & Concepts
HydroxychloroquineChloroquineCoronavirus disease 2019 (COVID-19)MedicineCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseasePandemicVirologyIntensive care medicinePharmacologyInternal medicineImmunologyInfectious disease (medical specialty)MalariaOutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Vitamin C and Antioxidants Research